IP Library Granted Patent US 7,781,160
Granted Patent B2
US 7,781,160 · App. 11/871,752 · Granted Aug 24, 2010

Biomarkers related to metabolic age and methods using the same

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,781,160
App. No.
11/871,752
Granted
Aug 24, 2010
Kind
B2
Abstract

Biomarkers relating to metabolic age are provided, as well as methods for using such biomarkers as biomarkers for determining metabolic age. In addition, methods for modulating the metabolic age of a subject are also provided. Also provided are suites of small molecule entities as biomarkers for metabolic age.

Claims (10)

1. A method for determining the metabolic age of a subject comprising the steps of:

a) analyzing a biological sample from a subject to determine the level(s) of glycine and one or more biomarkers for metabolic age in the sample, wherein the one or more biomarkers are selected from the group consisting of alanine, glutamine, normetanephrine, ornithine and valine and

b) comparing the level(s) of glycine and the one or more biomarkers in the sample to metabolic age reference levels of glycine and the one or more biomarkers to determine the subject's metabolic age.

2. The method of claim 1 , wherein the level(s) of the one or more biomarkers in the sample are compared to a biochemical age index to determine the subject's metabolic age.

3. The method of claim 1 , wherein levels of glycine and the one or more biomarkers in the sample are similar to metabolic age reference levels corresponding to an older chronological age are indicative of a negative metabolic age.

4. The method of claim 1 , wherein levels of glycine and the one or more biomarkers in the sample are similar to metabolic age reference levels corresponding to a younger chronological age are indicative of a positive metabolic age.

5. The method of claim 1 , wherein the biological sample is blood plasma.

6. The method of claim 1 , wherein the reference level(s) are tailored to a population selected from the group consisting of gender, race and combinations thereof.

7. The method of claim 1 , wherein said subject is a male subject.

8. The method of claim 1 , wherein said subject is a female subject.

Assignments (10)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR'S NAME FROM " PERCEPTIVE CREDIT HOLDINGS ILL, LP" TO "PERCEPTIVE CREDIT HOLDINGS III, LP" PREVIOUSLY RECORDED AT REEL: 66971 FRAME: 0054. ASSIGNOR(S) HEREBY CONFIRMS THE RELEASE OF SECURITY INTEREST. Recorded Apr 4, 2024
From: PERCEPTIVE CREDIT HOLDINGS III, LP
To: METABOLON, INC.
Reel/Frame 067019/0662 →
RELEASE OF SECURITY INTEREST Recorded Apr 1, 2024
From: PERCEPTIVE CREDIT HOLDINGS ILL, LP
To: METABOLON, INC.
Reel/Frame 066971/0054 →
SECURITY AGREEMENT Recorded Jul 24, 2020
From: METABOLON, INC.
To: PERCEPTIVE CREDIT HOLDINGS III, LP
Reel/Frame 053313/0406 →
RELEASE OF SECURITY INTEREST Recorded Jul 23, 2020
From: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
To: METABOLON, INC.
Reel/Frame 053290/0441 →
SECURITY INTEREST Recorded Jun 10, 2020
From: METABOLON, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
Reel/Frame 052902/0736 →
RELEASE OF SECURITY INTEREST Recorded Jul 10, 2018
From: MIDCAP FUNDING IV TRUST
To: METABOLON, INC.; LACM, INC.
Reel/Frame 047247/0568 →
RELEASE OF SECURITY INTEREST Recorded Jul 10, 2018
From: MIDCAP FUNDING IV TRUST
To: METABOLON, INC.; LACM, INC.
Reel/Frame 047247/0658 →
SECURITY INTEREST (TERM LOAN) Recorded Jun 15, 2016
From: METABOLON, INC.; LACM, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 039024/0396 →
SECURITY INTEREST (REVOLVING LOAN) Recorded Jun 15, 2016
From: METABOLON, INC.; LACM, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 039024/0422 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2008
From: RYALS, JOHN; MILBURN, MIKE; MITCHELL, MATTHEW W.; LAWTON, KAY A.
To: METABOLON, INC.
Reel/Frame 020488/0697 →